LAMICTAL        SUPPORTING DATA 
Prevents depression
Does not destabilize mood
Improves quality of life
Tolerability similar to placebo
No weight gain
13 years of experience
A new approach
Supporting data
Introduce at any phase
Can be used in combination
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Economic assessment of bipolar therapy

Authors: Bowden et al.
Title: Pharmacotherapy for bipolar depression: an economic assessment.
Reference: Expert Opinion on Investigational Drugs (In press).
Purpose: To review the cost of pharmacotherapy for the treatment of bipolar depression.
Conclusions: The depressive pole of bipolar disorder is associated with the highest economic burden. Preventing depressive episodes with long-term maintenance treatment reduces this burden and associated health risks. The prevention of such episodes is more likely to be achieved with recent evidence-based treatments.

 
  
home help sitemap acronyms help sitemap home